Land: Verenigd Koninkrijk
Taal: Engels
Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cefuroxime axetil
Mawdsley-Brooks & Company Ltd
J01DC02
Cefuroxime axetil
250mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010201
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SZ00901LT05A WHAT IS IN THIS LEAFLET: 1. What Cefuroxime is and what it is used for 2. What you need to know before you take Cefuroxime 3. How to take Cefuroxime 4. Possible side effects 5. How to store Cefuroxime 6. Contents of the pack and other information Cefuroxime is an antibiotic used in adults and children. It works by killing bacteria that cause infections. It belongs to a group of medicines called_ cephalosporins._ Cefuroxime is used to treat infections of: • the throat • sinus • middle ear • the lungs or chest • the urinary tract • the skin and soft tissues. Cefuroxime can also be used: • to treat Lyme disease (an infection spread by parasites called ticks). DO NOT TAKE CEFUROXIME: • if you are allergic (hypersensitive) to any cephalosporin antibiotics or any of the other ingredients of this medicine (listed in section 6). • if you have ever had a severe allergic (hypersensitive) reaction to any other type of betalactam antibiotic (penicillins, monobactams and carbapenems). If you think this applies to you, DONʼT TAKE Cefuroxime until you have checked with your doctor. WARNINGS AND PRECAUTIONS Cefuroxime IS NOT RECOMMENDED FOR CHILDREN AGED UNDER 3 MONTHS, as the safety and effectiveness are not known in this age group. You must look out for certain symptoms, such as allergic reactions, fungal infections (such as_ candida_) and severe diarrhoea_ (pseudomembranous colitis)_ while you are taking Cefuroxime. This will reduce the risk of any problems. See ʻConditions you need to look out forʼ in Section 4. IF YOU NEED A BLOOD TEST Cefuroxime can affect the results of a test for blood sugar levels, or a blood screen called the_ Coombs test._ If you need a blood test: TELL THE PERSON TAKING THE SAMPLE that you are taking Cefuroxime. OTHER MEDICINES AND CEFUROXIME Tell your doctor or pharmacist if you are taking any other medicines, if youʼve started taking any recently or you start taking new ones. This includes medicines you can obtain w Lees het volledige document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cefuroxime 250mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Cefuroxime 250 mg Tablets contain 300.72 mg cefuroxime axetil which is equivalent to 250 mg cefuroxime per tablet. Excipients with known effect: 1 tablet contains 0.3 mg aspartame (E951) For the full list of excipients: see section 6.1. 3. PHARMACEUTICAL FORM Coated tablets White to slightly yellowish, biconvex, oblong tablets scored on both sides 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cefuroxime tablets are indicated for the treatment of mild to moderately severe infections caused by micro-organisms susceptible to cefuroxime, such as: - upper respiratory tract infections: acute otitis media, sinusitis, tonsillitis and pharyngitis - acute bronchitis, acute exacerbations of chronic bronchitis - lower uncomplicated urinary tract infections: cystitis - skin and soft tissue infections: furunculosis, pyoderma and impetigo - treatment of early stage Lyme disease (stage I) and subsequent prevention of late complications in adults and children above 12 years of age. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Posology The usual course of therapy is seven days (may range from five to ten days). _Table 1. Adults and children (_ ≥ _40 kg) _ Indication Dosage Acute tonsillitis and pharyngitis, acute bacterial sinusitis 250 mg twice daily Acute otitis media 500 mg twice daily Acute exacerbations of chronic bronchitis 500 mg twice daily Cystitis 250 mg twice daily Pyelonephritis 250 mg twice daily Uncomplicated skin and soft tissue infections 250 mg twice daily Lyme disease 500 mg twice daily for 14 days (range of 10 to 21 days) _Table 2. Children (<40 kg) _ _ _ Indication Dosage Acute tonsillitis and pharyngitis, acute bacterial sinusitis 10 mg/kg twice daily to a maximum of 125 mg twice daily Children aged two years or older with otitis media or, where appropriate, with more severe Lees het volledige document